Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643

Toxicology and Applied Pharmacology

Volumn 145, Issue 2, 1997, Pages 425-436

  Obourn, John D ^a   Frame, Steven R ^a   Bell Jr , Richard H ^b   Longnecker, Daniel S ^c   Elliott, Glenn S ^a   Cook, Jon C ^a  

^a DUPONT COMPANY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; CLOFIBRATE; METHYLCLOFENAPATE; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; SOYBEAN TRYPSIN INHIBITOR; TRYPSIN;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHOLESTASIS; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PANCREAS CANCER; PANCREAS ISLET CELL HYPERPLASIA; RAT;

ANIMALIA; GLYCINE MAX;

EID: 0031213559     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8210     Document Type: Article

References (57)

1. Appel M. J., Meijers M., Garderen-Hoetmer A. V., Lamers C. B. H. W., Rovati L. C., Sprij-Mooij D., Jansen J. B. M. J., Woutersen R. A. Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats. Br. J. Cancer. 66:1992;46-50.
2. Ashby J., Brady A., Elcombe C. R., Elliott B. M., Ishmael J., Odum J., Tugwood J. D., Kettle S., Purchase I. F. H. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13:1994;S1-S117.
3. Bell R. H., Kuhlmann E. T., Jensen R. T., Longnecker D. S. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. Cancer Res. 52:1992;3295-3299.
4. Bentley P., Calder I., Elcombe C., Grasso P., Stringer D., Wiegand H.-J. Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 32:1993;857-907.
5. Biegel L. B., Hurtt M. E., Frame S. R., Applegate M., O'Connor J. C., Cook J. C. Comparison of the effects of Wyeth-14,643 in Crl:CDBR and Fisher-344 rats. Fundam. Appl. Toxicol. 19:1992;590-597.
6. Booth A. N., Robbins D. J., Ribelin W. E., Deeds F. Effects of raw soybean meal and amino acids on pancreatic hypertrophy in rats. Proc. Soc. Exp. Biol. Med. 104:1960;681-683.
7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
8. Clegg E. D., Cook J. C., Chapin R. E., Foster P. M. D., Daston G. P. Leydig cell hyperplasia and adenoma formation: Mechanisms and relevance to humans. Reprod. Toxicol. 11:1997;107-121.
9. Cook J. C., Hurtt M. E., Frame S. R., Biegel L. B. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in Crl:CDBR rats. Toxicologist. 14:1994;1169.
10. Cook J. C., Frame S. R., Obourn J. D. Leydig cell tumors. Comprehenive Toxicology. 1997;Pergamon, New York. p. 193-201.
11. Delzenne N. M., Taper H. S., Toberfroid M. Modifications of liver bile acids pool during modulation of rat hepatocarcinogenesis by phenobarbital and nafenopin. Arch. Toxicol. 68:1994;394-397.
12. Faccini J. M., Abbott D. P., Paulus G. J. J. Mouse Histopathology. A Glossary for Use in Toxicity and Carcinogenicity Studies. 1990;Elsevier, New York.
13. Goke B., Fenchel K., Knobloch S., Arnold R. R., Adler G. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats. Pancreas. 3:1988;576-579.
14. Gomez G., Upp J. R., Lluis F., Alexander R. W., Poston G. J., Greeley G. H., Thompson J. C. Regulation of the release of cholecystokinin by bile salts in dogs. Gastroenterology. 94:1988;1036-1046.
15. Hopman W., Jansen J., Lamers C. Plasma cholecystokinin response to oral fat in patients with Billroth I and Billroth II gastrectomy. Ann. Surg. 199:1984;276-280.
16. Hurtt M. E., Elliott G. S., Cook J. C., Obourn J. D., Frame S. R., Biegel L. B. Induction of coagulation effects by Wyeth-14,643 in Crl:CD®BR rats. Drug Chem. Toxicol. 20:1997;1-10.
17. Innis R. B., Snyder S. H. Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. USA. 77:1980;6239-6243.
18. Iwai K., Fushiki T., Fukuoka S.-I. Pancreatic enzyme secretion mediated by novel peptide: Monitor peptide hypothesis. Pancreas. 3:1988;720-728.
19. Izydore R. A., Hall I. H. Hypolipodemic activity of aliphatic dicarboxylic acids in rodents. Acta Pharm. Nord. 3:1991;141-146.
20. Johnson L. R. Effects of gastrointestinal hormones on pancreatic growth. Cancer. 47:1981;1640-1645.
21. Johnson L. R. Cholesystokinin. Johnson L. R., Christensen J., Jackson M. J., Jacobson G. D., Walsh J. H. Physiology of the Gastrointestinal Tract. 1987;195-205 Raven Press, New York.
22. Koide M., Okabyashi Y., Otusuki M. Role of endogenous bile on basal and postprandial CCK release in humans. Dig. Dis. Sci. 38:1993;1284-1290.
23. Koop I., Koop H., Gerhardt C., Schafmayer A., Arnold R. Do bile acids exert a negative feedback control of cholecystokinin release? Scand. J. Gastroenterol. 24:1989;315-320.
24. Kurosawa H., Miyasaka K., Kitani K. Influence of bile flow obstruction vs. bile diversion on pancreatic secretion in the conscious rat. Int. J. Pancreatol. 4:1989;187-197.
25. Lazarow P. B. Assay of peroxisomal beta-oxidation of fatty acids. Methods Enzymol. 72:1981;315-319.
26. Li Y., Hao Y., Owyang C. Evidence for autoregulation of cholecystokinin secretion during diversion of bile pancreatic juice in rats. Gastroenterology. 109:1995;231-238.
27. Liddle R. A., Green G. M., Conrad C. K., Williams J. A. Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Am. J. Physiol. 14:1986;G243-G248.
28. Longnecker D. S. Early morphologic markers of carcinogenicity in rat pancreas. Milman H., Sell S. Application of Biological Markers to Carcinogen Testing. 1983;43-60 Plenum, New York.
29. Longnecker D. S. Interface between adaptive and neoplastic growth in the pancreas. Gut. 28:1987;253-258.
30. Longnecker D. S., Sumi C. Effects of sex steroid hormones on pancreatic cancer in the rat. Int. J. Pancreatol. 7:1990;159-165.
31. Malley L. A., Carakostas M., Hansen J. F., Rusch G. M., Kelly D. P., Trochimowicz H. J. Two-year inhalation toxicity study in rats with hydrochlorofluorocarbon 123. Fundam. Appl. Toxicol. 25:1995;101-114.
32. Marsman D. S., Cattley R. C., Conway J. G., Popp J. A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48:1988;6739-6744.
33. Neptun D. A., Cattley T. C., Popp J. A. Bile acid profiles and serum enzyme alterations in rats fed the hepatocarcinogenic peroxisome proliferator Wyeth 14,643. Clin. Chem. 34:1988;1196.
34. Nustede R., Schmidt W. E., Kohler H., Folsch U. R., Schafmayer A. The influence of bile acids on the regulation of exocrine pancreatic secretion and on the plasma concentrations of neurotensin and CCK in dogs. Int. J. Pancreatol. 13:1993;23-30.
35. Oates P. S., Morgan G. R., Light A. M. Cell death (apoptosis) during pancreatic involution after raw soya flour. Am. J. Physiol. 250:1986;G9-G14.
36. Obourn J. D., Frame S. R., Chiu T., Solomon T. E., Cook J. C. Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism. Toxicol. Appl. Pharmacol. 1997.
37. Ohta H., Guan K., Tawail T., Liddle R. A., Green G. M. Regulation of plasma cholecystokinin levels by bile and bile acids in the rat. Gastroenterology. 90:1990;819-825.
38. Oishi S., Oishi H., Hiraga K. The effect of food restriction for 4 weeks on common toxicity parameters in male rats. Toxicol. Appl. Pharmacol. 47:1979;15-22.
39. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification and properties. J. Biol. Chem. 239:1964;2379-2385.
40. Physician's Desk Reference. 1996;Medical Economics Co. Montvale. p. 2701-2703.
41. Povoski S. P., Zhou W., Longnecker D. S., Bell R. H. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Oncol. Res. 6:1995;411-417.
42. Reddy J. K., Rao M. S. Transplantable pancreatic carcinoma of the rat. Science. 198:1977a;78-80.
43. Reddy J. K., Rao M. S. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator. J. Natl. Cancer Inst. 59:1977b;1645-1650.
44. Roebuck B. D., Kaplita P. V., Edwards B. R., Praissman M. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. Cancer Res. 47:1987;1333-1338.
45. Roebuck B. D., Wilpone S. A., Fifield D. S., Yager J. D. Jr. Hemorrahagic deaths with AIN-76 diet. J. Nutr. 109:1979;924-925.
46. Roze C., Cuchet P., Souchard M., Vaille C., Debray C. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat. Eur. J. Pharmacol. 43:1977;57-64.
47. Salmon G. K., Leslie G., Roe F. J. C., Lee P. N. Influence of food intake and sexual segregation on longevity, organ weights and the incidence of non-neoplastic and neoplastic diseases in rats. Food Chem. Toxicol. 28:1990;39-48.
48. Santilli A. A., Scotese A. C., Tomarelli R. M. Experentia. 30:1974;1110.
49. Spannagel A. W., Green G. M., Guan D., Liddle R. A., Faull K., Reeve J. R. Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc. Natl. Acad. Sci. USA. 93:1996;4415-4420.
50. Svoboda D. J., Azarnoff D. L. Tumors in male rats fed ethylchlorophenoxyisobutyrate, a hypolipidemic drug. Cancer Res. 39:1979;3419-3428.
51. Toriumi Y., Samuel I., Wilcockson D. P., Turkleson C. M., Solomon T. E., Joehl R. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. J. Surg. Res. 54:1993;132-135.
52. Tucker M. J., Orten T. C. Comparative Toxicology of Hypolipidaemic Fibrates. 1995;Taylor and Francis Inc. Bristol.
53. Turkelson C. M., Dale W. E., Reidelberger R., Solomon T. E. Development of cholecystokinin radioimmunoassay using synthetic CCK-10 as immunogen. Regul. Pept. 15:1986;205-217.
54. Wada N., Marsman D. S., Popp J. A. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell proliferation. Fundam. Appl. Toxicol. 18:1992;149-154.
55. Wennogle L., Steel D., Petrack B. Characterization of central CCK receptors using a radioiodinated octapeptide probe. Life Sci. 36:1985;1485-1492.
56. Zhou W., Povoski S. P., Bell R. H. Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma. Carcinogenesis. 14:1993;2189-2192.
57. Zhou W., Povoski S. P., Longnecker D. S., Bell R. H. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: Receptor determination and characterization. Cancer Res. 52:1992;6905-6911.